Print Page     Close Window     

SEC Filings

6-K
IKANG HEALTHCARE GROUP, INC. filed this Form 6-K on 12/21/2018
Entire Document
 

 

Dental Services: Net revenues for the quarter were US$4.6 million, which remained stable compared to US$4.6 million in the same period of the last fiscal year.

 

Other Services: Net revenues for the quarter were US$13.0 million, representing an 18.1% increase from US$11.0 million in the same period of the last fiscal year.

 

Cost of Revenues

 

Cost of revenues for the quarter was US$96.0 million, representing a 17.4% increase from US$81.7 million in the same period of the last fiscal year.

 

Gross Profit and Gross Margin

 

Gross profit for the quarter was US$81.7 million, representing a 15.6% increase from US$70.7 million in the same period of the last fiscal year. Gross margin for the quarter was 46.0%, as compared to 46.4% in the second quarter of the last fiscal year.

 

Operating Expenses

 

Total operating expenses for the quarter was US$53.5 million, representing a 39.9% increase from US$38.2 million in the same period of the last fiscal year.

 

Selling and marketing expenses

 

Selling and marketing expenses for the quarter were US$26.8 million, accounting for 15.1% of total net revenues as compared to 12.9% in the same period of the last fiscal year.

 

General and administrative expenses

 

General and administrative expenses for the quarter were US$25.7 million, accounting for 14.5% of total net revenues as compared to 11.7% in the same period of the last fiscal year.  Excluding share-based compensation expenses of US$234,000 for this quarter and US$389,000 for the same quarter of the last fiscal year, the general and administrative expenses for the quarter was US$25.5 million, accounting for 14.3% of total net revenue as compared to 11.4% in the same period of the last fiscal year.

 

Research and development expenses

 

Research and development expenses for the quarter were US$0.9 million, accounting for 0.5% of total net revenues as compared to 0.5% in the same period of the last fiscal year.

 

Income from Operations

 

Income from operations for the quarter was US$28.2 million, representing a 13.0% decrease from US$32.4 million in the same period of the last fiscal year. Excluding share-based compensation expenses of US$234,000 for this quarter and US$389,000 for the same quarter of the last fiscal year, non-GAAP income from operations for the quarter was US$28.5 million as compared to US$32.8 million, which reflected a decrease of 13.3%.

 

Non-GAAP EBITDA

 

Non-GAAP EBITDA for the quarter was US$38.8 million, representing a 10.2% decrease from US$43.2 million in the same period of the last fiscal year.

 

Net Income

 

Net income attributable to the Company for the quarter was US$16.1 million, representing a decrease of 17.2% from US$19.5 million in the same period of the last fiscal year.

 

Non-GAAP net income attributable to the Company for the quarter was US$16.4 million, representing a decrease of 17.7% from US$19.9 million in the same period of the last fiscal year.

 

Basic and Diluted Earnings per ADS

 

Basic and diluted income per ADS attributable to common shareholders were US$0.23 and US$0.22, respectively, as compared to US$0.28 and US$0.28, respectively, in the same quarter of 2017.

 

Non-GAAP basic and diluted income per ADS attributable to common shareholders were US$0.23 and US$0.23, respectively, as compared to US$0.29 and US$0.29, respectively, in the same quarter of 2017.

 

3



Copyright © 2015- iKang Healthcare Group, Inc. All Rights Reserved.